--- title: "China's welding-robot leader CRP refiles for Hong Kong IPO on rising sales, red ink" date: 2026-10-18 category: Capital & Markets site: NeuroAI canonical: https://neuroai.site/a/na-capital-crp-welding-robot-ipo language: en --- # China's welding-robot leader CRP refiles for Hong Kong IPO on rising sales, red ink > Chengdu CRP Robot Technology (卡诺普), ranked China's top welding-robot maker by revenue in 2025, refiled its Hong Kong prospectus on May 31, 2026 after an earlier attempt lapsed. A Chengdu factory floor where robots weld steel frames is also where a listing story is being stress-tested. CRP Robot Technology (卡诺普) wants to be the first Chinese welding-robot maker on the Hong Kong board — but its books show the classic hard-technology tension: sales climbing while losses deepen. The company refiled its prospectus on May 31, 2026, after an earlier attempt quietly expired. ## A second swing at the same door CRP first submitted a main-board application to the Hong Kong Stock Exchange on November 17, 2025, with Guotai Junan as sole sponsor. That filing lapsed without a hearing, as many do, and the company came back on May 31, 2026, this time sponsored by Guotai Haitong (国泰海通). The refiling keeps CRP in the race to be branded China's "welding-robot first stock." Founded in 2012, CRP did not start as a full robot builder. It began with controllers — the brains that direct a robot's arm — and only moved into complete machines around 2018. That controller-first heritage is central to its pitch: control the underlying software and motion layer, and you keep flexibility over cost, iteration, and which industrial scenarios you can enter. ## The numbers behind the claim CRP's revenue has grown steadily across its last three reported years: - 2023: RMB 222 million (≈ US$31M) - 2024: RMB 234 million (≈ US$33M) - 2025: RMB 324 million (≈ US$45.6M), up 38.5% year on year Gross margin improved in step, from 27.1% in 2023 to 30.4% in 2024 and 33.0% in 2025, a sign that product mix is tilting toward higher-value systems. But profit tells a different story: - 2023: a slim net profit of RMB 1.69 million (≈ US$0.24M). - 2024: a net loss of RMB 12.94 million (≈ US$1.8M). - 2025: a net loss of RMB 16.15 million (≈ US$2.3M). The company explains the red ink through higher R&D, bigger sales spending, and lower government grants — the usual profile of a pre-scale industrial automation firm buying its way into new customers. ## Why welding is the wedge According to Frost & Sullivan data cited in the prospectus, CRP ranked first among Chinese welding-robot manufacturers by revenue in 2025. Welding is a deliberately chosen battleground: it demands precise motion control and deep process know-how, which favors players that own the control layer rather than assembling bought-in parts. The product line splits into three buckets: - Industrial robots, still the core, contributed RMB 264 million (≈ US$37M) in 2025, or 81.4% of revenue, with six-axis welding arms the largest piece. - Collaborative robots, at RMB 24.3 million (≈ US$3.4M), about 7.5%. - Embodied intelligence robots, at RMB 24.1 million (≈ US$3.4M), about 7.4% — small today but the growth story the IPO is meant to fund. CRP says it held 326 patents and 44 software copyrights as of May 2026, and that its robots shipped to customers in 40 countries and regions outside China, including Germany and Japan. ## The cracks a sponsor will have to explain No IPO in this segment sails through uncontested, and CRP carries a recognizable list of soft spots. - **Supplier concentration.** In 2025, CRP's top five suppliers accounted for 37.9% of purchases, with its largest single supplier at 20.2%. A disruption there hits production directly. - **Overseas exposure is shrinking.** Domestic sales were 88.7% of revenue in 2025, and the share of overseas income fell from 19.0% in 2023 after the company stopped direct sales to Russia in 2024 over trade-policy exposure. - **Cash pressure.** Trade receivables and bills reached RMB 143 million (≈ US$20M) in 2025, with a receivables cycle of about 120 days — meaningful for a firm still funding losses from operations. - **Valuation risk.** As a Chapter 18C specialist-technology issuer, CRP carries the explicit warning that its securities are hard to value and prone to volatility. ## What the raise is for The prospectus states the net proceeds are intended for R&D to upgrade core technology and lift product competitiveness, expanding the product portfolio and application scenarios, and building out domestic and overseas commercialization. In plain terms: CRP wants capital to push its embodied robots from demonstration into paid industrial deployment before competitors lock in the same factories. ## What readers can do now - Read the HKEX filing (app number referenced in filings) for audited figures rather than secondary summaries, which sometimes round or restate the loss numbers. - Watch whether CRP's embodied-robot revenue line grows past its current ~7% share — that is the metric that separates a welding-robot maker from an "AI robotics" story. - Compare CRP against listed and filing peers in industrial robotics to judge whether a first-mover "welding" label justifies a premium at listing. ## Honest limitations This article is built from Chinese financial-media reporting (Eastmoney, ifeng, TopNews, Tencent Securities, and Caifins) that quotes CRP's May 31, 2026 prospectus; it did not independently access the full HKEX filing or audited statements. Revenue, loss, margin, and patent figures are consistent across those sources but remain company-disclosed pending exchange review. The "first/ranked #1" claim derives from Frost & Sullivan's commissioned report inside the prospectus, a paid analysis that readers should weight accordingly. Not covered: exact IPO size and price range (not yet set at writing), detailed order backlog, and the identity and terms of pre-IPO investors. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-capital-crp-welding-robot-ipo Free to quote with attribution and a link to the original.